Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis [6]

Clinical and Experimental Rheumatology

Volumn 22, Issue 6, 2004, Pages 790-

  Ortiz García, Ana M ^a   Gonzalez Alvaro I ^a   Rosello Pardo R ^b   Carmona, L ^c   Fabregas Canales M D ^b   Monteagudo Saez, I ^d   Bascones Ilundain, Miriam ^d   Caro Fernández, Natividad ^d   del Castillo Montalvo, Rosa ^d   García Vacuña, Rosario ^a   Juan Mas, Antonio ^e   Rivera Redondo, Javier ^f   Tomero Muriel, Eva ^g  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL SAN JORGE   (Spain)

^c UNIDAD DE INVESTIGACIÓN   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL SON LLÀTZER   (Spain)

^f Instituto Provincial de Rehabilitacion   (Spain)

^g HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE;

BACTERIAL ENDOCARDITIS; CARDIOGENIC SHOCK; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SAFETY; FOLLOW UP; HUMAN; INFECTION; LETTER; LIVER DYSFUNCTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES;

EID: 19944413027     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. GODINHO F, GODFRIN B, EL MAHOU S, NAVAUX F, ZABRANIECKI L, CANTAGREL A: Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol 2004; 22: 328-30.
2. KIELY PD, JOHNSON DM: Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study: Rheumatology (Oxford) 2002; 41: 631-7.
3. HANSEN K, CUSH J, SINGAL A, COOLEY D, COHEN S, PATEL S et al.: The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis (RA): Arthritis Rheum 2004; 51: 228-32.
4. Arthritis Drug Advisory Committee: Update on the TNF-α blocking agents. Available at: http://www.fda.gov/ohrms/dockets/ac/03/briefIng/ 39308101B-TNF.Briefing.htm Accessed May 2004.